Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour

Sreelatha Sarangapani, Ajeetkumar Patil, Yoke Keng Ngeow, Rosmin Elsa Mohan, Anand Asundi, Matthew J. Lang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Targeting the oxidative stress response has recently emerged as a promising strategy for the development of therapeutic drugs for a broad spectrum of diseases. Supporting this strategy, we have reported that chitosan nanoparticles synthesized with a controlled size had selective cytotoxicity in leukemia cells through the mechanism related to reactive oxygen species (ROS) generation. Herein, we found that the cellular uptake of chitosan nanoparticles was enhanced in a time dependent manner and inhibited the cellular proliferation of leukemia cells in a dose dependent manner with elevation of the reactive oxygen species (ROS) showing a stronger effect on apoptosis, associated with the upregulation of caspase activity and the depletion of reduced glutathione. Propidium iodide and calcein staining demonstrated the central role of the chitosan nanoparticles in triggering elevated ROS, inducing cell death and intracellular oxidative activity. The enhanced free radical scavenging activity of the chitosan nanoparticles further iterates its antioxidant activity. In vitro quantitative phase imaging studies at the single cell level further demonstrated the inhibition of cellular proliferation with significant changes in cellular behavior and this supported our hypothesis. Hemocompatibility tests demonstrated that chitosan nanoparticles could be used safely for in vivo applications. Our findings suggest that chitosan nanoparticles may be a promising redox active candidate for therapeutic applications.

Original languageEnglish
Pages (from-to)313-324
Number of pages12
JournalIntegrative Biology (United Kingdom)
Volume10
Issue number5
DOIs
Publication statusPublished - 01-05-2018

Fingerprint

Scavenging
Chitosan
Cytotoxicity
Nanoparticles
Oxidation-Reduction
Pharmaceutical Preparations
Reactive Oxygen Species
Leukemia
Cell Proliferation
Oxidative stress
Propidium
Cell death
Caspases
Free Radicals
Glutathione
Oxidative Stress
Cell Death
Up-Regulation
Antioxidants
Apoptosis

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry

Cite this

Sarangapani, Sreelatha ; Patil, Ajeetkumar ; Ngeow, Yoke Keng ; Elsa Mohan, Rosmin ; Asundi, Anand ; Lang, Matthew J. / Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour. In: Integrative Biology (United Kingdom). 2018 ; Vol. 10, No. 5. pp. 313-324.
@article{dd4f4b6a82f445e7bc81ad043f0dffb4,
title = "Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour",
abstract = "Targeting the oxidative stress response has recently emerged as a promising strategy for the development of therapeutic drugs for a broad spectrum of diseases. Supporting this strategy, we have reported that chitosan nanoparticles synthesized with a controlled size had selective cytotoxicity in leukemia cells through the mechanism related to reactive oxygen species (ROS) generation. Herein, we found that the cellular uptake of chitosan nanoparticles was enhanced in a time dependent manner and inhibited the cellular proliferation of leukemia cells in a dose dependent manner with elevation of the reactive oxygen species (ROS) showing a stronger effect on apoptosis, associated with the upregulation of caspase activity and the depletion of reduced glutathione. Propidium iodide and calcein staining demonstrated the central role of the chitosan nanoparticles in triggering elevated ROS, inducing cell death and intracellular oxidative activity. The enhanced free radical scavenging activity of the chitosan nanoparticles further iterates its antioxidant activity. In vitro quantitative phase imaging studies at the single cell level further demonstrated the inhibition of cellular proliferation with significant changes in cellular behavior and this supported our hypothesis. Hemocompatibility tests demonstrated that chitosan nanoparticles could be used safely for in vivo applications. Our findings suggest that chitosan nanoparticles may be a promising redox active candidate for therapeutic applications.",
author = "Sreelatha Sarangapani and Ajeetkumar Patil and Ngeow, {Yoke Keng} and {Elsa Mohan}, Rosmin and Anand Asundi and Lang, {Matthew J.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1039/c8ib00038g",
language = "English",
volume = "10",
pages = "313--324",
journal = "Integrative Biology (United Kingdom)",
issn = "1757-9694",
publisher = "Royal Society of Chemistry",
number = "5",

}

Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour. / Sarangapani, Sreelatha; Patil, Ajeetkumar; Ngeow, Yoke Keng; Elsa Mohan, Rosmin; Asundi, Anand; Lang, Matthew J.

In: Integrative Biology (United Kingdom), Vol. 10, No. 5, 01.05.2018, p. 313-324.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour

AU - Sarangapani, Sreelatha

AU - Patil, Ajeetkumar

AU - Ngeow, Yoke Keng

AU - Elsa Mohan, Rosmin

AU - Asundi, Anand

AU - Lang, Matthew J.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Targeting the oxidative stress response has recently emerged as a promising strategy for the development of therapeutic drugs for a broad spectrum of diseases. Supporting this strategy, we have reported that chitosan nanoparticles synthesized with a controlled size had selective cytotoxicity in leukemia cells through the mechanism related to reactive oxygen species (ROS) generation. Herein, we found that the cellular uptake of chitosan nanoparticles was enhanced in a time dependent manner and inhibited the cellular proliferation of leukemia cells in a dose dependent manner with elevation of the reactive oxygen species (ROS) showing a stronger effect on apoptosis, associated with the upregulation of caspase activity and the depletion of reduced glutathione. Propidium iodide and calcein staining demonstrated the central role of the chitosan nanoparticles in triggering elevated ROS, inducing cell death and intracellular oxidative activity. The enhanced free radical scavenging activity of the chitosan nanoparticles further iterates its antioxidant activity. In vitro quantitative phase imaging studies at the single cell level further demonstrated the inhibition of cellular proliferation with significant changes in cellular behavior and this supported our hypothesis. Hemocompatibility tests demonstrated that chitosan nanoparticles could be used safely for in vivo applications. Our findings suggest that chitosan nanoparticles may be a promising redox active candidate for therapeutic applications.

AB - Targeting the oxidative stress response has recently emerged as a promising strategy for the development of therapeutic drugs for a broad spectrum of diseases. Supporting this strategy, we have reported that chitosan nanoparticles synthesized with a controlled size had selective cytotoxicity in leukemia cells through the mechanism related to reactive oxygen species (ROS) generation. Herein, we found that the cellular uptake of chitosan nanoparticles was enhanced in a time dependent manner and inhibited the cellular proliferation of leukemia cells in a dose dependent manner with elevation of the reactive oxygen species (ROS) showing a stronger effect on apoptosis, associated with the upregulation of caspase activity and the depletion of reduced glutathione. Propidium iodide and calcein staining demonstrated the central role of the chitosan nanoparticles in triggering elevated ROS, inducing cell death and intracellular oxidative activity. The enhanced free radical scavenging activity of the chitosan nanoparticles further iterates its antioxidant activity. In vitro quantitative phase imaging studies at the single cell level further demonstrated the inhibition of cellular proliferation with significant changes in cellular behavior and this supported our hypothesis. Hemocompatibility tests demonstrated that chitosan nanoparticles could be used safely for in vivo applications. Our findings suggest that chitosan nanoparticles may be a promising redox active candidate for therapeutic applications.

UR - http://www.scopus.com/inward/record.url?scp=85047434715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047434715&partnerID=8YFLogxK

U2 - 10.1039/c8ib00038g

DO - 10.1039/c8ib00038g

M3 - Article

VL - 10

SP - 313

EP - 324

JO - Integrative Biology (United Kingdom)

JF - Integrative Biology (United Kingdom)

SN - 1757-9694

IS - 5

ER -